Found 4 matching trials
Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients
PHASE1The safety and tolerability of hLF 1-11 given in multiple doses has to be e...
Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients
PHASE1The safety and tolerability of hLF 1-11 has to be established first in HSCT...
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis
PHASE1The purpose of this study is to establish the tolerability of treatment wit...
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia
PHASE1This is a phase-I, double-blind, randomized study with hLF1-11 to study the...